{"version":"1.0","provider_name":"Basel Area Business &amp; Innovation","provider_url":"https:\/\/test.baselarea.swiss\/de\/","author_name":"martin","author_url":"https:\/\/test.baselarea.swiss\/de\/author\/martin\/","title":"Basilea erh\u00e4lt F\u00f6rderung f\u00fcr neues Antibiotikum","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ai1GM8fbRX\"><a href=\"https:\/\/test.baselarea.swiss\/de\/blog-post\/basilea-erhalt-forderung-fur-neues-antibiotikum\/\">Basilea erh\u00e4lt F\u00f6rderung f\u00fcr neues Antibiotikum<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/test.baselarea.swiss\/de\/blog-post\/basilea-erhalt-forderung-fur-neues-antibiotikum\/embed\/#?secret=ai1GM8fbRX\" width=\"600\" height=\"338\" title=\"&#171;Basilea erh\u00e4lt F\u00f6rderung f\u00fcr neues Antibiotikum&#187; &#8212; Basel Area Business &amp; Innovation\" data-secret=\"ai1GM8fbRX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/test.baselarea.swiss\/\/wp-content\/uploads\/2020\/08\/Pharma-e1639150343823.jpg","thumbnail_width":800,"thumbnail_height":533,"description":"Die Initiative CARB-X vergibt eine F\u00f6rdersumme von 2,7 Millionen Dollar an die Basler Pharmafirma Basilea. Damit wird die Entwicklung eines Antibiotikums aus einer neuen Wirkstoffklasse unterst\u00fctzt. Basilea bek\u00e4mpft mit seinem Programm Infektionen durch resistente Bakterien."}